StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3010% above fair value
$923.34−22.19 (-2.35%)

Close on Nov 19, 2026Market cap $95.52BP/E 20.4Yield –

Regeneron Pharmaceuticals Net Product Sales Recorded by Regeneron

Net Product Sales Recorded by Regeneron ($M) ($M)

Regeneron Pharmaceuticals Net Product Sales Recorded by Regeneron: $1,805M in Q3 2026, up 13.7% from a year earlier.

Latest, Q3 2026
1,805
Period ended Sep 30, 2026
Change on a year earlier
+13.7%
1,588 in Q3 2025
History
38 quarters
Since Q2 2017
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-30) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Note 2.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Product Sales Recorded by Regeneron ($M) ($M)Year on yearSource
Q3 2026Sep 30, 20261,805+13.7%Form 10-Q (filed 2026-10-30) ↗
Q2 2026Jun 30, 20261,642+0.7%Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 20261,535+8.4%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 20251,675-16.4%Form 10-K (filed 2026-02-04) ↗
Q3 2025Sep 30, 20251,588-18.4%Form 10-Q (filed 2026-10-30) ↗
Q2 2025Jun 30, 20251,631-15.0%Form 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 20251,416-19.6%Form 10-Q (filed 2026-04-29) ↗
Q4 2024Dec 31, 20242,003+8.2%Form 10-K (filed 2026-02-04) ↗
Q3 2024Sep 30, 20241,946+9.0%Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 20241,919+8.3%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 20241,761+5.6%Form 10-Q (filed 2025-04-29) ↗
Q4 2023Dec 31, 20231,852+9.0%Form 10-K (filed 2026-02-04) ↗
Q3 2023Sep 30, 20231,786-0.8%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 20231,772+1.0%Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 20231,668+1.8%Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 20221,699-57.3%Form 10-K (filed 2025-02-05) ↗

Breakdown

What makes up net Product Sales Recorded by Regeneron

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Net Product Sales Recorded by Regeneron ($M), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-prod-total

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?